We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Nasal Filter Alleviates Hay Fever Symptoms

By HospiMedica International staff writers
Posted on 25 Mar 2014
A small filter the size of a contact lens could make life easier for some of the estimated 500 million people worldwide who suffer from seasonal allergic rhinitis (hay fever).

Under development by researchers at Aarhus University (Denmark), the Rhinix mini-filter is designed to be inserted in both nostrils simultaneously, and can be used both in professional and social settings, as well as during sleep. More...
Depending on the filter's density, it can block specific particles in the air, including pollen from grass, which is one of the most frequent causes of hay fever. When inserted correctly the filter is nearly invisible.

The researchers conducted a single-center, randomized placebo-controlled crossover clinical trial in an environmental exposure unit (EEU) at Aarhus University on 24 subjects with proven seasonal allergic rhinitis due to allergy to grass. A total nasal symptom score (TNSS), consisting of nasal congestion, nasal discharge, nasal itching, and sneezing was used as the primary outcome measure. TNSS was rated nine times during each study day and evaluated based on the difference in daily TNSS and maximum daily TNSS.

The results showed that Rhinix reduced daily TNSS by 21%, daily sneezing by 45%, maximum itching by 46%, and maximum sneezing by 38%, when compared to placebo. Conversly, Rhinix showed a nonsignificant reduction in the primary efficacy endpoint of difference in maximum TNSS, with a mean reduction of 14% and median reduction of 33% when compared to placebo. The nasal filters were well tolerated and measurements showed that there was no difference in airflow between the placebo filter and the Rhinix filter. The study was published online on March 3, 2014, in the Journal of Allergy and Clinical Immunology.

“We will test Rhinix on a larger scale in collaboration with the Danish Patient Organization Asthma-Allergy Denmark later in the year,” said seniorstudy author Prof. Torben Sigsgaard, MD, PhD. “But the preliminary tests in our allergy chamber show that the filter can both alleviate typical symptoms and that you will not experience unacceptable discomfort when using it.”

Allergic rhinitis is an allergic inflammation of the nasal airways. It occurs when an allergen, such as pollen, dust, or animal dander is inhaled by an individual with a sensitized immune system. In such individuals, the allergen triggers the production of the antibody immunoglobulin E (IgE), which binds to mast cells and basophils containing histamine. When caused by pollens of any plants, it is called pollinosis, and, if specifically caused by grass pollens, it is known as hay fever. While symptoms resembling a cold or flu can be produced by an allergic reaction to pollen from plants and grasses, including those used to make hay, it does not cause a fever.

Related Links:

Aarhus University 



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.